Mar 17, 2020 3-5PM ET
Tuesday on The Robert Scott Bell Show:
Bay Area orders ‘shelter in place,’ only essential businesses open in 6 counties Six Bay Area counties announced “shelter in place” orders for all residents on Monday — the strictest measure of its kind yet in the continental United States — directing everyone to stay inside their homes and away from others as much as possible for the next three weeks in a desperate move to curb the rapid spread of coronavirus across the region. The directive was set to begin at 12:01 a.m. Tuesday and involves San Francisco, Santa Clara, San Mateo, Marin, Contra Costa and Alameda counties — a combined population of more than 6.7 million. It is to stay in place until at least April 7. The three other Bay Area counties — Sonoma, Solano and Napa — did not issue similar mandates. Just outside the Bay Area, Santa Cruz County late Monday also announced a “shelter in place” order for its 275,000 residents. The orders — which are all similarly worded — fall just short of a full lockdown, which would forbid people from leaving their homes without explicit permission. The orders (read San Francisco’s here in its entirety at tinyurl.com/waddyqv) call for county and city sheriffs and police chiefs to “ensure compliance,” and local authorities said they would not “rush to enforce” the directives as residents adjusted to understand what activities are no longer allowed. Violation of the orders is considered a misdemeanor punishable by a fine or jail time.
Volunteers fight virus by testing new experimental vaccine The first people to roll up their sleeves to receive an experimental vaccine for the coronavirus say they were inspired to help because they wanted to do more to fight the disease than wash their hands and work from home. Three of the study participants spoke to The Associated Press on Monday following the trial’s first injections in Seattle. They said the shots were no more painful than an ordinary season flu vaccine. Some will get higher dosages than others to test how strong the dose should be. They will be checked for side effects and have their blood tested to determine whether the vaccine is revving up their immune systems. The volunteers said they weren’t acting in hopes of protecting themselves. They understand their role is a small part of what could be an 18-month hunt for a successful shot that could be distributed widely. They work in the tech industry and in health research. Two have children, and all three are working from home to slow the spread of COVID-19. They are a 43-year-old operations manager at a small tech company, a 46-year-old network engineer at Microsoft and a 25-year-old editorial coordinator at an independent global health research center at the University of Washington.
Special Guest – Stuart Tomc!
Stuart Tomc serves as a Sciences, Regulatory, Education Vice President at CV Sciences, Inc. He is a recognized authority on dietary supplements, with twenty years of experience in the nutritional health industry. He served as Vice President of North American Herb and Spice, where he served for 10 years, in addition to his service as Global Educator for omega-3 market leader, Nordic Naturals, Mr. Tomc is known for
Immunity & Anxiety – CVSI COVID statement Immunity & Anxiety The Food and Drug Administration prohibits dietary supplements from claiming to prevent, treat, cure, or mitigate a disease. Furthermore, there is zero evidence that hemp or CBD would be an effective prevention or treatment for the current COVID-19 pandemic. CV Sciences appreciates that consumers are concerned and looking for natural ways to balance immune health and reduce anxiety that can result from these uncertain times. CV Sciences provides this background discussion of how hemp derived CBD may interact with the immune system, as well as help to manage stress. Nothing in this memo should be considered medical advice. Always talk to your doctor about any dietary supplements that you take. The endocannabinoid system (ECS) serves as a master control switch for balancing the immune system. Each system is complex, and when they interact it compounds the complexity. Scientists are still discovering how the ECS works and emerging evidence suggests that the ECS has a biphasic effect on the immune system. The cannabinoids (both phyto- and endo-) that signal the ECS are not defined as immunostimulatory or immunosuppressing. They are thought to have immunomodulatory effect.
Labeling of Cannabidiol Products:A Public Health Perspective Interest in the therapeutic use of cannabidiol (CBD) has reached a fever-pitch in recent months, asCBD-containing products appear Labeling of Cannabidiol Products_ A Public Health Perspective_MacKay everywhere from online retailers to grocery stores and gas stations. The widespreadavailability of hemp-derived CBD products is confounding given that CBD is a U.S. Food and Drug Administration(FDA)-approved drug, and thus precluded from being added to food and beverages, or included in dietary supple-ments. The use by manufacturers of disease-related claims on marketing materials and product labels, along with thefederal legalization of hemp in December 2018, has created political pressure on FDA to promulgate regulations.Conclusions:Accurate and informative labeling of hemp and hemp-derived CBD products is an important pub-lic health issue. FDA-regulated product labels are considered an essential tool for protecting consumers and en-abling informed decision-making. Untruthful or unsubstantiated health-related claims, and unallowed DrugClaims, in marketing materials and on labels of CBD products may create harm by enticing consumers toforgo more evidence-based medical interventions. Furthermore, missing or inaccurate labeling of the amountof CBD, delta-9 tetrahydrocannabinol (THC), and potentially harmful contaminants such as pesticides, naturally-occurring yeast and mold or heavy metals may result in harm and/or lack of efficacy. Manufacturers of theseproducts may reasonably be expected to understand and adhere to FDA regulations for labeling and marketingof food, dietary supplements and drugs, both over-the-counter (OTC) and prescription, even though FDA hasinterpreted federal law as excluding them from these categories. As manufacturers prepare for forthcoming reg-ulations, a better understanding of the basic framework for FDA labeling and marketing regulations for food,dietary supplements and drugs is warranted.
Your Ultimate Beginner’s Guide to CBD Oil In 2018, the Farm Bill removed CBD oil from the Controlled Substances Act Schedule 1 designation, allowing the sell and purchase of hemp CBD oil products. Since then, CBD oil has been a popular topic in the news, on social media and in conversation of the American population. Many myths and legends about CBD have been passed around the media, making it hard for people to learn the truth. That’s why we’ve created this ultimate guide to CBD for beginners. If you’ve been searching for answers to all your CBD questions, search no longer because this guide is for you. CBD Explained CBD is harvested from the hemp plant. You may have heard of hemp for its use in rope and fabric making and its connection to its infamous cousin: cannabis. Hemp’s relationship to cannabis gives it a false reputation. CBD is one of many cannabinoids, which are the active ingredients in both hemp and cannabis plants. While other cannabinoids, like THC, are illegal in the United States (except under certain state regulations) CBD is available to purchase and consume almost everywhere in the country. The most important thing to know is CBD is non-intoxicating. Here’s why: Cannabinoids work in your body through the endocannabinoid system (ECS). This system consists of receptors, called CB1 and CB2. When activated, CB1 and CB2 are responsible for the “high” and the addictiveness commonly associated with cannabis. The cannabinoid-receptor interaction doesn’t just determine psychoactivity and addictiveness. The way CBD affects receptors throughout your body, giving beneficial contributions to your body.
Special Guest Maryam Henein
Maryam Henein is an investigative journalist, functional medicine consultant, and founder and editor-in-chief of HoneyColony. She is also the director of the award-winning documentary film Vanishing of the Bees, narrated by Ellen Page.
On March 12, 2020, Roche received FDA Emergency Use Authorization for the cobas® SARS-CoV-2 Test to detect the virus that causes COVID-19, which the WHO has classified as a pandemic. Hospitals and reference laboratories can run the test on Roche’s fully automated cobas® 6800 and cobas® 8800 Systems, which are widely available in the U.S. and around the world.
How does the test work?
The test detects the genetic signature (RNA) of the SARS-CoV-2 virus in swab samples that a healthcare provider collects from the back of the patient’s throat or nose.
Where is the test performed?
Healthcare providers can send patient samples to hospital and reference laboratories across the U.S. to run the test. There will be more than 30 laboratory sites across the U.S. that will conduct the test initially.
Where is the test made?
Roche designed the test in California and produces it in New Jersey. The cobas 6800/8800 Systems are made in Switzerland.
How fast is the test?
After the lab starts the test, results are available in about 3.5 hours. The instruments can process up to 384 results (cobas 6800 System) and 960 results (cobas 8800 System) in an 8-hour shift.
02/18/2020: Lab Advisory: Reminder: COVID-19 Diagnostic Testing The Food and Drug Administration (FDA) granted an Emergency Use Authorizationexternal icon (EUA) for the CDC 2019-Novel Coronavirus (COVID-19) Real-Time RT-PCR Diagnostic Panel which is to be used in qualified laboratories for testing patient respiratory specimens that meet CDC criteria for COVID-19 testing. This message is to remind clinical laboratories that this is currently the only EUA assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19. Any laboratory that is not designated by CDC as a qualified laboratory and is implementing a COVID-19 diagnostic test other than the CDC EUA assay must contact the FDA to obtain an EUA before any COVID-19 diagnostic testing may be performed in their facilities. The Secretary of Health and Human Services issued an emergency declarationexternal icon that justifies the authorization of emergency use of in vitro diagnostics for the detection of SARS-CoV-2 and the diagnosis of COVID-19. All tests for SARS-CoV-2, including laboratory developed tests (LDTs), must be reviewed and cleared or authorized by the FDA for emergency use, or they cannot be used for diagnostic testing. The FDA requests that developers of such LDTs submit information about their testsexternal icon to help FDA better understand their design, validation, and performance characteristics. For more details, please refer to FDA: Information for Laboratories Implementing IVD Tests Under EUAexternal icon. Qualified laboratories for use of the CDC-distributed 2019-nCoV Real-Time RT-PCR Diagnostic Panel, as defined by the EUA, include select U.S. state and local public health laboratories and Department of Defense laboratories. Diagnostic testing with this assay can only be done at CDC and by these qualified laboratories. The state and local public health laboratories are in the process of implementing the CDC EUA assay.
Strictly by the numbers, the coronavirus does not register as a dire global crisis In the three months or so since it started, the new coronavirus and its related COVID-19 disease – which emerged in the Chinese province of Hubei late in 2019 and now numbers more than 110,000 cases around the world – have caused more than 4,000 deaths, mostly in China. As the case numbers grow around the world, including in Canada, where there are now more than 70 cases, people have become concerned that a pandemic is inevitable. But in the same three months, there have been about three million deaths in China from other causes, and about 14 million deaths worldwide. During the same three-month period, according to Health Canada, there have been almost 10,000 deaths in Canada from tobacco addiction, for instance – and just one from COVID-19. Is COVID-19 a global crisis? Certainly for people who can’t add. I learned some powerful lessons from SARS in 2003. Maybe the most important one was how important it was to focus on what has happened rather than on what might happen. In other words: “Just the facts, ma’am.”
Israeli virologist urges world leaders to calm public, slams ‘unnecessary panic’ A leading Israeli virologist on Sunday urged world leaders to calm their citizens about the coronavirus pandemic, saying people were being whipped into unnecessary panic. Prof. Jihad Bishara, the director of the Infectious Disease Unit at Petah Tikva’s Beilinson Hospital, said that some of the steps being taken in Israel and abroad were very important, but the virus is not airborne, most people who are infected will recover without even knowing they were sick, the at-risk groups are now known, and the global panic is unnecessary and exaggerated. “I’ve been in this business for 30 years,” Bishara said in a Channel 12 interview. “I’ve been through MERS, SARS, Ebola, the first Gulf war and the second, and I don’t recall anything like this. There’s unnecessary, exaggerated panic. We have to calm people down. “People are thinking that there’s a kind of virus, it’s in the air, it’s going to attack every one of us, and whoever is attacked is going to die,” he said.
France says ibuprofen may aggravate coronavirus. Experts say more evidence is needed France’s health ministry has suggested that popular anti-inflammatory painkillers such as ibuprofen could worsen the effects of the coronavirus, raising questions over which over-the-counter drugs people should be taking to treat the symptoms of the disease.Health Minister Olivier Veran, who has also worked as a neurologist, tweeted on Saturday that “taking anti-inflammatory drugs (ibuprofen, cortisone…) could be an aggravating factor of the infection. If you have a fever, take paracetamol. If you are already on anti-inflammatory drugs or in doubt, ask your doctor for advice.” His suggestion was criticized by some health experts, who cited the lack of publicly available evidence suggesting a link between ibuprofen and adverse effects of the coronavirus. There is currently no published scientific evidence that the virus is worsened by ibuprofen. Nonetheless, Veran’s recommendation came on the same day that the French government reported that “grave adverse effects” linked to the use of non-steroidal anti-inflammatory drugs (NSAID) — the family of drugs that includes ibuprofen — have “been identified with patients affected by Covid-19, in potential or confirmed cases.”
Remember Friends, The Power to Heal is Yours!
More upcoming RSB events:
- NOCO Hemp Expo, Denver CO – March 27-28, 2020 Delayed!
- Be Healthy Utah Conference, Sandy UT April 17-18, 2020 Delayed!
- MAHO Expo Convention & Trade Show, Columbus OH – July 24-26, 2020